DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results
COPENHAGEN, Denmark, 28 February 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the fourth quarter of 2023 (“Q4-2023”). The Q4-2023 report is available as an attached document to this press release and at www.dancann.com.Summary: Group Key Figures Q4-2023 DKK 1,000 01/01/23 01/01/22 01/10/23 01/10/22 01/01/22 –31/12/23 –31/12/22 – 31/12/23 – 31/12/22 – 31/12/22 Net sales: 6,073 5,707 1,611 2,101